Variables |
CC+CT |
TT |
P-value a
|
OR (95% CI) |
P-value
|
Adjusted OR (95% CI)
b |
P-value
b
|
|
Patients/controls |
Patients/controls |
|
|
|
|
|
Age, months |
Age, months |
Age, months |
Age, months |
Age, months |
Age, months |
Age, months |
Age, months |
<12 |
219/271 |
14/13 |
0.468 |
1.333(0.614-2.894) |
0.4681 |
1.327(0.609-2.888) |
0.4763 |
12-60 |
179/312 |
15/11 |
0.0326 |
2.377(1.068-5.286) |
0.0338 |
2.413(1.083-5.376) |
0.0311 |
>60 |
45/69 |
2/2 |
0.6757 |
1.533(0.208-11.280) |
0.6746 |
1.551(0.210-11.431) |
0.6669 |
Gender |
Gender |
Gender |
Gender |
Gender |
Gender |
Gender |
Gender |
Male |
285/382 |
16/17 |
0.5161 |
1.262(0.627-2.540) |
0.5152 |
1.244(0.617-2.508) |
0.5411 |
Female |
158/270 |
15/9 |
0.0137 |
2.848(1.218-6.658) |
0.0157 |
2.868(1.226-6.714) |
0.0152 |
Sepsis subtypes |
Sepsis subtypes |
Sepsis
subtypes |
Sepsis subtypes |
Sepsis subtypes |
Sepsis subtypes |
Sepsis subtypes |
Sepsis
subtypes |
sepsis |
90/652 |
9/26 |
0.0334 |
2.508(1.139-5.522) |
0.0224 |
2.533(1.149-5.586) |
0.0213 |
severe sepsis |
272/652 |
18/26 |
0.1142 |
1.660(0.895-3.077) |
0.1077 |
1.631(0.878-3.032) |
0.1218 |
septic shock |
81/652 |
4/26 |
0.7042 |
1.238(0.422-3.638) |
0.6973 |
1.240(0.421-3.653) |
0.6962 |
Prognosis |
|
|
|
|
|
|
|
Survivors |
367/652 |
27/26 |
0.0309 |
1.845(1.061-3.209) |
0.0301 |
1.822(1.046-3.175) |
0.0343 |
Non-survivors |
76/652 |
4/26 |
0.6251 |
1.320(0.449-3.884) |
0.6138 |
1.334(0.451-3.943) |
0.6024 |
Number of organs with dysfunction, n (%) |
Number of
organs with dysfunction, n (%) |
Number of organs with
dysfunction, n (%) |
Number of organs with dysfunction, n
(%) |
Number of organs with dysfunction, n (%) |
Number of organs with dysfunction, n (%) |
|
|
1-2 |
260/652 |
16/26 |
0.1915 |
1.543(0.815-2.924) |
0.1832 |
1.499(0.787-2.853) |
0.2178 |
3 or more |
89/652 |
6/26 |
0.2847 |
1.691(0.677-4.221) |
0.2607 |
1.720(0.687-4.310) |
0.2469 |
Note: a χ2 tests were used
to determine differences in genotype distributions between the patients
with sepsis and the healthy controls. b Adjusted for
age and gender. The values are shown in bold if P <
0.05. |
Note: a χ2 tests
were used to determine differences in genotype distributions between the
patients with sepsis and the healthy controls. b
Adjusted for age and gender. The values are shown in bold if P
< 0.05. |
Note: a
χ2 tests were used to determine differences in
genotype distributions between the patients with sepsis and the healthy
controls. b Adjusted for age and gender. The values
are shown in bold if P < 0.05. |
Note:
a χ2 tests were used to determine
differences in genotype distributions between the patients with sepsis
and the healthy controls. b Adjusted for age and
gender. The values are shown in bold if P < 0.05. |
Note: a χ2 tests were used
to determine differences in genotype distributions between the patients
with sepsis and the healthy controls. b Adjusted for
age and gender. The values are shown in bold if P <
0.05. |
Note: a χ2 tests
were used to determine differences in genotype distributions between the
patients with sepsis and the healthy controls. b
Adjusted for age and gender. The values are shown in bold if P
< 0.05. |
Note: a
χ2 tests were used to determine differences in
genotype distributions between the patients with sepsis and the healthy
controls. b Adjusted for age and gender. The values
are shown in bold if P < 0.05. |
Note:
a χ2 tests were used to determine
differences in genotype distributions between the patients with sepsis
and the healthy controls. b Adjusted for age and
gender. The values are shown in bold if P <
0.05. |
Abbreviations: CI, confidence interval; OR, odds ratio. |
Abbreviations: CI, confidence interval; OR, odds ratio. |
Abbreviations: CI, confidence interval; OR, odds ratio. |
Abbreviations: CI, confidence interval; OR, odds ratio. |
Abbreviations: CI, confidence interval; OR, odds ratio. |
Abbreviations: CI, confidence interval; OR, odds ratio. |
Abbreviations: CI, confidence interval; OR, odds ratio. |
Abbreviations: CI, confidence interval; OR, odds
ratio. |